Real-world treatment patterns and healthcare costs of biologics and apremilast among patients with moderate-to-severe plaque psoriasis by metabolic condition status by Steven R. Feldman, Jingchuan Zhang, Diane J. Martinez, Lorena Lopez-Gonzalez, Elizabeth Hoit Marchlewicz, George Shrady, Alan M. Mendelsohn, Yang Zhao

Get full text